Should Doctors Know The Cost Of Lab Tests?

By Admin
If doctors were better informed about the cost of lab tests, they would request fewer of them for their patients or look for cheaper alternatives, Hopk...

If doctors were better informed about the cost of lab tests, they would request fewer of them for their patients or look for cheaper alternatives, Hopkins researchers have found.

Research conducted at The Johns Hopkins Hospital put the price on some blood tests for six months and found use of tests declined 9 percent. The hospital saved $400,000 over the six month period.

Read Related Articles On Healthcare Global

The results of the study were published online in JAMA Internal Medicine.

Hospitals don't normally display the price of tests to doctors. “We generally don’t make decisions based on what is cost-effective or what is known to be absolutely necessary for our patients, but knowing the cost of things appears to make us more thoughtful about what we think might be best for their health,” Dr. Leonard S. Feldman, an assistant professor of medicine at the Johns Hopkins University School of Medicine and leader of the study, said in a statement. 

“There’s a lot of waste in medicine because we don’t have a sense of the costs of much of what we do.”

Doctors generally chose the cheaper test when shown the prices. The exception was the most expensive diagnostic tests. Researchers said that was likely because those were specialized tests with no alternative.

Feldman said the study's results don't necessarily mean doctors should always choose the less expensive test. Sometimes it is best to order many tests when doctors are stumped about the diagnosis of a patient. The tests may be cheaper than keeping the patient in the hospital while doctors figure out what is wrong.

Share
Share

Featured Articles

Digital healthcare platform Balanced supports healthy ageing

10,000 people turn 65 in the USA each day. Digital healthcare platform Balanced wants to help them better manage healthy ageing, says CEO Katie Reed

TrueBinding’s antibody drugs fight Alzheimer’s Disease

Dongxu Sun, CEO at TrueBinding, shares how its research & antibody drug development is fighting illnesses such as Alzheimer’s Disease, stroke & more

Cardinal Health’s clinically integrated pharma supply chain

Peter J. Siavelis, SVP & General Manager, Health System & Provider Distribution & Services at Cardinal Health, discusses the integrated pharma supply chain

Healthcare Digital news roundup: digital healthcare & AI

Digital Healthcare

Hospitals must embrace IoMT device security

Hospitals

Mental health support for working women and mothers

Digital Healthcare